Vital Farms director buys 5,000 shares

Vital Farms director Karl Khoury bought 5,000 shares of Common Stock in an open-market purchase at a weighted average price of $18.45 per share.

Rhea-AI Filing Summary

Vital Farms director Karl Khoury bought 5,000 shares of Common Stock in an open-market purchase at a weighted average price of $18.45 per share. After this transaction, he directly owns 119,789 shares. The shares were acquired in multiple trades at prices ranging from $18.41 to $18.47.

Insider Trade Summary

Net Buyer: 5,000 shares

Net Buy 1 txn

Insider Khoury Karl

Role Director

Bought 5,000 shs ($92K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$18.45	$92K

Holdings After Transaction: Common Stock — 119,789 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.41 to $18.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

FAQ

What insider transaction did Vital Farms (VITL) report for Karl Khoury?

Karl Khoury, a director of Vital Farms, bought 5,000 shares of Common Stock in an open-market transaction. The weighted average purchase price was $18.45 per share, reflecting multiple trades within a narrow intraday price range.

At what price did Karl Khoury buy Vital Farms (VITL) shares?

Karl Khoury purchased 5,000 Vital Farms shares at a weighted average price of $18.45 per share. Individual trades occurred between $18.41 and $18.47, according to the disclosed pricing range in the transaction footnote.

How many Vital Farms (VITL) shares does Karl Khoury own after this trade?

After the reported purchase, Karl Khoury directly owns 119,789 shares of Vital Farms Common Stock. This figure reflects his holdings immediately following the 5,000-share open-market acquisition disclosed in the Form 4 filing.

Was the Vital Farms (VITL) insider transaction a purchase or a sale?

The reported Vital Farms insider transaction was a purchase. Director Karl Khoury executed an open-market buy of 5,000 Common Stock shares, classified in the filing with transaction code P for a purchase in the open market or private transaction.

Were Karl Khoury’s Vital Farms (VITL) share purchases executed in a single trade?

No, the 5,000 Vital Farms shares were bought through multiple trades. The filing notes a weighted average price of $18.45, with individual transaction prices ranging from $18.41 to $18.47 for the purchased shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khoury Karl

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE C100

(Street)

AUSTIN TX 78704

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		P		5,000	A	$18.45(1)	119,789	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.41 to $18.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

	/s/ Francis Cullo, Attorney-in-Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.